• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Is Big Pharma getting too much Flak From Doctors?

Article

Big Pharma's image problem, fueled by numerous high-profile scandals, may have made doctors so skeptical of the industry that it's warping their judgment, a new survey suggests.

Researchers found that doctors shown summaries of hypothetical drug tests lost their confidence in the results when a pharmaceutical company had paid for the studies.

Read the full story: http://reut.rs/PIjhyI

Source: Reuters

Related Videos
Senator Vincent Polistina (R, New Jersey)
Senator Vincent Polistina (R, New Jersey)
Jeffrey Fitzgerald, JD
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy (AMCP)
Related Content
Affordable Care Act | Image credit: Yauhen - stock.adobe.com

ACA Premiums Set for Significant Jumps in 2026, Threatening Affordability

August 13th 2025
Article

Proposed Affordable Care Act (ACA) premium hikes threaten health care access, with potential increases of over 75% for enrollees.

Read More

The Center for Biosimilars podcast banner

Follow the Science: Bridging the Biosimilar Gap With Dr Hillel Cohen

July 29th 2025
Podcast

Listen

RSV, COVID, Flu vaccines. | Image credit: angellodeco - stock.adobe.com

RFK Jr Axes $500 Million in Funding for mRNA Vaccine Development

August 6th 2025
Article

Robert F. Kennedy Jr halted 22 mRNA vaccine initiatives, drawing criticism from health experts over pandemic preparedness concerns.

Read More

Managed Care Cast

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

July 15th 2025
Podcast

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

Listen

US medicine. | Image Credit: Andreas Prott - stock.adobe.com

Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order

July 31st 2025
Article

President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.

Read More

cognition and alzheimer's disease/dementia | Image credit: Orawan - stock.adobe.com

Proposed SNAP Cuts Could Threaten Prevention for Cognitive Decline, Dementias

July 30th 2025
Article

Supplemental Nutrition Assistance Program (SNAP) benefits may slow cognitive decline in older adults, highlighting the importance of food assistance in combating Alzheimer disease and dementia risks.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.